[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362337-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362337-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","artificial-intelligence-for-breast-cancer-management-review","Artificial intelligence for breast cancer management - review","","Artificial intelligence is transforming breast cancer management through machine learning and deep learning applied to precision medicine. By analyzing medical imaging, histopathology, histopathology-related data, genomics and multi-omics sources, AI supports detection, diagnosis, prognosis, and prediction of treatment response while aiming to improve patient recovery. The review synthesizes AI-driven advances across the care continuum, assesses efficacy and limitations, and examines effects on healthcare costs and clinical practice. It highlights challenges in generalisability, reproducibility and regulatory barriers and notes limited but emerging roles for generative AI, while emphasizing the need for rigorous validation and equitable implementation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/artificial-intelligence-for-breast-cancer-management-review/362337/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/artificial-intelligence-for-breast-cancer-management-review/362337.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does AI support precision medicine in breast cancer management?","Question",{"text":63,"@type":64},"AI enhances detection, diagnosis, prognosis, and treatment-response prediction by analyzing data from medical imaging, histopathology, genomics, and multi-omics sources.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which AI techniques are most commonly used in current breast cancer research?",{"text":68,"@type":64},"Machine learning and deep learning dominate most current AI research, including recurrent neural networks, transfer learning, and convolutional neural networks for improved accuracy in several studies.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the main barriers to translating AI benefits into clinical practice?",{"text":72,"@type":64},"Translation requires rigorous validation, transparent model development, and equitable implementation, while addressing challenges such as generalisability, reproducibility, and regulatory barriers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362337,1790742245,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","A Nature Portfolio journal  \n[https://doi.org/10.1038/s43856-025-01342-3](https://doi.org/10.1038/s43856-025-01342-3)  \nArtiﬁcial intelligence for breast cancer management  \n Check for updates  \n\n| Bryan Nicholas Chua 1,2, Dexter Kai Hao Thng 2, Tan Boon Toh 1,2,3  & Dean Ho 1,2,4,5  |  |\n| --- | --- |\n| Artiﬁcial intelligence is transforming breast cancer management through various machine learning applications. Artiﬁcial intelligence supports precision medicine by enhancing detection, diagnosis, prognosis, and treatment response prediction. It achieves this by analysing data from medical imaging, histopathology, genomics and multi-omics sources to improve patient recovery. This review summarises AI-driven advancements across the entire continuum of breast cancer management, spanning detection, diagnosis, prognosis, treatment and recovery. It evaluates their efﬁcacy and limitations, explores their impact on healthcare costs and clinical practice, and addresses key challenges including generalisability, reproducibility and regulatory barriers. Evidence from recent studies highlights AI’s role in improving breast cancer detection, molecular subtyping and prognostic accuracy. It also facilitates more patient-tailored therapeutic strategies and supports quality of life interventions. Nonetheless, the translation of these beneﬁts into clinical practice requires rigorous validation, transparent model development, and equitable implementation. |  |\n| Breast cancer is the most commonly diagnosed cancer among women globally, with an estimated 2.3 million new cases reported in 2022 . It is a complex and heterogeneous disease that can quickly develop into a metastatic, drug-resistant state1. Breast cancer is also the leading cause of cancer mortality among women, with 666,000 deaths recorded in the same year2.\u003Cbr>Over recent decades, technological advancements have improved the detection and treatment of breast cancer. In particular, the adoption of artiﬁcial intelligence(AI)in medical imaging and therapeutics has enhanced breast cancer diagnosis and therapy planning, while reducing operational costs, time and labour3–5. AI refers totheuse ofcomputational methods that mimic human neural processes to process vast amounts of data and carryout tedious tasks, such as image recognition and predictive analyses. Within breast cancer care, the most widely applied techniques include machine learning, which builds predictive models by identifying patterns in data, and deep learning, which refers to a subset of machine learning that leverages neural networks to extract increasingly complex features from large datasets. These methods have demonstrated strength in medical imaging, pathology, and genomics, where high-dimensional inputs are difﬁcult to interpret manually. A recent review encompassing more than 300 breast cancer AI studies has shown that performance varies substantially depending on algorithm selection, with recurrent neural networks, transfer learning, and convolutional neural networks (CNNs) achieving higher accuracies | compared to conventional machine learning methods, while decision trees often underperform due to overﬁtting6.\u003Cbr>In addition to machine learning and deep learning, which constitute the majority ofcurrent breast cancer AIresearch, it is important to note that generative AI represents a rapidly emerging ﬁeld. Based on the input information it receives, generative AI can create new content, including text and images. To date, however, its applications in breast cancer care remain limited and largely restricted to diagnosis7. Several ofits applications, such as image augmentation8,9 and drug discovery10, also fall outside the primary scope of this review. Therefore, the use of generative AI tools is only brieﬂy acknowledged within this review.\u003Cbr>In the area of medical imaging, the use of AI in mammograms11, tomosynthesis12, magnetic resonance imaging(MRI)13 and ultrasound14 has improved the accuracy and speed ofbreast ","cbCaiuQ5jyWws8Qn","https://ap.wps.com/l/cbCaiuQ5jyWws8Qn","pdf",1765789,17,"English","# Overview\n## AI for precision medicine across the continuum\n# Methods and evidence\n## Machine learning and deep learning\n## Generative AI: emerging and limited use\n# Applications by care area\n## Medical imaging\n## Histopathology\n## Genomics and therapeutics\n# Impact and challenges\n## Cost savings and practitioner roles\n## Validation, reproducibility, and regulatory barriers","[{\"question\":\"How does AI support precision medicine in breast cancer management?\",\"answer\":\"AI enhances detection, diagnosis, prognosis, and treatment-response prediction by analyzing data from medical imaging, histopathology, genomics, and multi-omics sources.\"},{\"question\":\"Which AI techniques are most commonly used in current breast cancer research?\",\"answer\":\"Machine learning and deep learning dominate most current AI research, including recurrent neural networks, transfer learning, and convolutional neural networks for improved accuracy in several studies.\"},{\"question\":\"What are the main barriers to translating AI benefits into clinical practice?\",\"answer\":\"Translation requires rigorous validation, transparent model development, and equitable implementation, while addressing challenges such as generalisability, reproducibility, and regulatory barriers.\"}]","Artificial intelligence for breast cancer management - review | PDF",1790147187,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3970650d2b26e65733bcfd8637f2b0a.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa213dd99e3bb2d9f5b86ff14ac4961f.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4c46ec973fe8f125c83ad37bf059ed2.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6d3293f9346eb3c0510027a1cd72ef5.webp",980,1301]